CBD石油有什么帮助？

FDA选择宣布于26年2018月XNUMX日，即国际禁止药物滥用日批准GW Pharmaceuticals的Epidiolex（cannabidiol）口服液的市场准入。 The drug is approved for the treatment of rare and severe epilepsy, Dravet syndrome and Lennox-Gastaut syndrome.该药被批准用于治疗罕见和严重的癫痫，Dravet综合征和Lennox-Gastaut综合征。
Currently, this is the first new drug approved by the FDA to be marketed with purified cannabis extract.当前，这是FDA批准的第一种与纯化的大麻提取物一起销售的新药。 Its ingredient is purified cannabidiol (CBD), a cannabinoid with no euphoria side effects.它的成分是纯化的大麻二酚（CBD），一种没有兴奋感副作用的大麻素。 It won't bring the nerve stimulation effect caused by tetrahydrocannabinol (THC).它不会带来四氢大麻酚（THC）引起的神经刺激作用。 Its potential to treat epilepsy was validated in three randomized, double-blind, placebo-controlled clinical trials.在三项随机，双盲，安慰剂对照的临床试验中证实了其治疗癫痫的潜力。 In early January this year, the positive results in phase III clinical trial of the cannabinoid Epidiolex (cannabidiol) was published in Lancet, an authoritative medical journal.今年一月初，权威医学杂志《柳叶刀》发表了大麻素Epidiolex（cannabidiol）的III期临床试验的阳性结果。 This new drug has been awarded the FDA-issued fast-track qualification (for Dravet syndrome) and orphan drug qualification (for both epilepsies).该新药已获得FDA颁发的快速通道认证（针对Dravet综合征）和孤儿药物认证（针对两种癫痫症）。 After its listing application was accepted, the US FDA also granted its priority for assessment.在其上市申请被接受之后，美国FDA也授予了其优先评估权。 The approval for its listing is a recognition of therapeutic potential of this new drug, and it is also the first treatment to be approved for Dravet syndrome.批准上市是对这种新药治疗潜力的认可，也是第一种被批准用于Dravet综合征的疗法。
Hemp naturally grows in the northern hemisphere, which adapts to various climates, with no need to require artificial cultivation, has a growth cycle of 108-120 days, and its THC content is less than 0.3%.大麻在北半球自然生长，适应各种气候，不需要人工栽培，生长周期为XNUMX-XNUMX天，四氢大麻酚含量低于XNUMX％。 Interestingly, CBD competes with THC, while CBD can hinder the impact of THC on the human nervous system.有趣的是，CBD与THC竞争，而CBD可以阻碍THC对人类神经系统的影响。 Therefore, CBD has obtained the nickname of “anti-marijuana compound”.因此，生物多样性公约获得了“反大麻化合物”的绰号。

说到麻油的好处，它通常指的是 CBD油。 Although more research is still needed on尽管仍然需要更多的研究 CBD油，现有研究和临床证据为我们提供了一些线索：
1.癫痫病
A recent retrospective study in Israel showed that epileptic seizures were significantly reduced with medical cannabis of high CBD content.以色列最近的一项回顾性研究表明，高CBD含量的医用大麻可显着减少癫痫发作。 In this study, 52% of patients had at least a 50% reduction in seizures.在这项研究中，XNUMX％的患者癫痫发作减少了至少XNUMX％。 
2.焦虑
根据2011年的一项研究，研究人员发现 CBD油 与安慰剂相比，焦虑和认知障碍明显减少。
3.缓解疼痛
Some animal studies have shown that topical use of cannabis oil can improve pain and inflammation.一些动物研究表明，局部使用大麻油可改善疼痛和炎症。 However, most of the data presented showed the most effective analgesic combination is CBD and THC.但是，大多数数据显示最有效的止痛药组合是CBD和THC。 
4.阿尔茨海默氏病
2014年的一项小规模研究表明，CBD油可预防阿尔茨海默氏病的常见症状，但需要更多的研究来验证这些发现。
5.用作抗氧化剂
这意味着它可以保护您的身体免受自由基的损害，并且CBD还被认为具有抗抑郁，抗恶心，保护肠道和平衡免疫系统的作用。